Status:
COMPLETED
Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Oregon Health and Science University
Conditions:
Choroidal Neovascularization
Age-Related Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
PHASE2
PHASE3
Brief Summary
Randomized controlled clinical trial of periocular corticosteroids as adjunctive therapy to photodynamic therapy (PDT) for patients with neovascular age-related macular degeneration (AMD). Patients un...
Eligibility Criteria
Inclusion
- Active choroidal neovascularization
- Age related macular degeneration
- Visual acuity 20/20 to 20/400
Exclusion
- Neovascular lesion \>6500 microns is greatest linear diameter
- More than one prior photodynamic therapy treatment
- Receiving systemic corticosteroids
- Intraocular pressure \> 21 mm Hg or glaucoma medication use
- History of glaucoma or history of ocular hypertension
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00305630
Start Date
July 1 2002
End Date
November 1 2005
Last Update
March 22 2006
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Univeristy School of Medicine
Baltimore, Maryland, United States, 21287
2
Oregon Health Science Univeristy
Portland, Oregon, United States, 97239